Products and services using Biohacking are generally available around 2022
Grader A: hit
Grader B: hit
agrees with A, without seeing its verdict
Audit: confirmed
in the fixed audit sample (D11)
Published: hit
Grader A: hit
The ODIN sold DIY CRISPR gene-editing kits to the public from 2016 for about $120; consumer genome and wearable self-tracking services were also on sale. Both senses of the label are met before 2022.
Test: D37 Horizons: biohacking kits or services buyable by ordinary consumers by 2024 (earlier counts).
Grader B: hit
DIY genetic engineering kits (The ODIN CRISPR kit, 2016), DNA tests (23andMe) and self-tracking wearables were on sale; non-prescription CGMs for self-optimisation followed (Dexcom Stelo, 2024).
Test: Consumers could buy biohacking products/services by 2024 (earlier counts).